3.22
Precedente Chiudi:
$3.19
Aprire:
$3.2
Volume 24 ore:
81,832
Relative Volume:
0.17
Capitalizzazione di mercato:
$123.37M
Reddito:
$2.76M
Utile/perdita netta:
$-49.12M
Rapporto P/E:
-2.1467
EPS:
-1.5
Flusso di cassa netto:
$-46.21M
1 W Prestazione:
+1.58%
1M Prestazione:
+0.00%
6M Prestazione:
-39.59%
1 anno Prestazione:
-59.75%
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Nome
Orchestra Biomed Holdings Inc
Settore
Industria
Telefono
646-343-9298
Indirizzo
150 UNION SQUARE DRIVE, NEW HOPE
Confronta OBIO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OBIO
Orchestra Biomed Holdings Inc
|
3.22 | 122.60M | 2.76M | -49.12M | -46.21M | -1.50 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-03-20 | Iniziato | BTIG Research | Buy |
2025-01-02 | Iniziato | Barclays | Overweight |
2024-08-22 | Iniziato | H.C. Wainwright | Buy |
2024-07-25 | Iniziato | B. Riley Securities | Buy |
2024-01-19 | Iniziato | Jefferies | Buy |
2023-02-24 | Iniziato | Piper Sandler | Overweight |
2023-02-07 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Orchestra Biomed Holdings Inc Borsa (OBIO) Ultime notizie
Is Orchestra BioMed Holdings Inc. a good long term investmentPowerful growth strategies - Autocar Professional
What drives Orchestra BioMed Holdings Inc. stock priceFree Advanced Stock Screener Access - Autocar Professional
Orchestra BioMed Holdings Inc. Stock Analysis and ForecastBreakthrough stock performance - Autocar Professional
What analysts say about Orchestra BioMed Holdings Inc. stockRapid market gains - jammulinksnews.com
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionFree Predictions - Newser
How Orchestra BioMed Holdings Inc. stock performs during market volatilityDouble Your Capital Alerts - Newser
What makes Orchestra BioMed Holdings Inc. stock price move sharplyMinimized Risk Trading Plan - Newser
How To Trade (OBIO) - news.stocktradersdaily.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Rating of “Buy” by Brokerages - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading Up 1.7% – Here’s What Happened - Defense World
Orchestra BioMed Secures FDA Clearance for Virtue Trial to Advance Coronary ISR Treatment - MSN
Orchestra BioMed to Present at Jefferies Global Healthcare Conference - MSN
Hedge funds owners may take dramatic actions as Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) recent 14% drop adds to one-year losses - simplywall.st
Learn to Evaluate (OBIO) using the Charts - news.stocktradersdaily.com
Orchestra BioMed: A Contrarian Gem in the Biotech Doldrums - AInvest
Orchestra BioMed Holdings, Inc.(NasdaqGM:OBIO) dropped from Russell Small Cap Comp Value Index - MarketScreener
Orchestra BioMed Confirms Director Elections and Auditor - TipRanks
Orchestra BioMed Showcases AVIM Therapy as Purpose-Built - GlobeNewswire
Millennium Management LLC Makes New Investment in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Citadel Advisors LLC Sells 7,836 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
(OBIO) Trading Advice - news.stocktradersdaily.com
Orchestra Biomed Reports Increased Losses Amid Revenue Growth - TipRanks
B. Riley Cuts Price Target on Orchestra BioMed Holdings to $12 From $15, Keeps Buy Rating - marketscreener.com
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Stake Increased by Northern Trust Corp - Defense World
Orchestra BioMed: Two Best-In-Class Devices And Promising Partnerships - Seeking Alpha
Orchestra BioMed Reports Q1 2025 Financial Results and Advances Key Clinical Programs - MSN
The Manufacturers Life Insurance Company Raises Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
FY2026 Earnings Estimate for OBIO Issued By Chardan Capital - Defense World
Orchestra Biomed Holdings Inc Azioni (OBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):